Poniard Pharmaceuticals Garners $6,300,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e5dadded-ff79-435b-b5ef-6bf8b94d3a40&Preview=1
Date
3/16/2010
Company Name
Poniard Pharmaceuticals
Mailing Address
7000 Shoreline Court South San Francisco, CA 94080
Company Description
Poniard Pharmaceuticals, Inc. (NASDAQ: PARD) is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer.
Website
http://investor.poniard.com
Transaction Type
Venture Equity
Transaction Amount
$6,300,000
Transaction Round
Undisclosed
Proceeds Purposes
The firm said the funding will go to fund continued development of its treatments for small cell lung cancer.
M&A Terms
Venture Investor
Undisclosed